New research reveals that patients who stop using new GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who halt traditional lifestyle plans.
Research printed in a prominent medical journal points out that while obese individuals can lose substantial amounts of their body weight while on the medication, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying these treatments should be informed of the risk of rapid rebound weight gain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.
That rate of regain suggests a return to starting mass in about one and a half years.
Weighing Treatments
The analysis, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of the injectable medications with conventional dieting.
The team note that people who lose weight through lifestyle changes alone generally have a slower creep back—perhaps 100 grams monthly—once they finish.
Explaining the Quick Rebound
Doctors propose the mechanism of the injections accounts for the heightened weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone levels several times higher than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this medication leads to appetite is unsuppressed, making excessive eating far more likely."
A Lifelong Issue?
Health authorities suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, given the likelihood of relapse, the treatment should be considered ongoing.
This view is supported by drug manufacturers, who say that the results "underscore the persistent character of excess weight," akin to managing diseases like diabetes.
User Testimonies
Users who have stopped the jabs explain a intense return of appetite.
"It felt as if a trigger that goes on and you become ravenous," recalled a patient.
The struggle is compounded if patients have not developed lasting lifestyle or habit modifications during treatment.
Growing Adoption
Survey data indicate that millions of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Adoption is more common among females than men.
- The middle-aged demographic shows the highest level of interest.
- Many access the medications through private healthcare rather than public health services.
In conclusion, experts stress that while the jabs are powerful tools for weight loss, they are not a magic solution and long-term success likely depends on integrated lifestyle changes.
